55.10
-0.36%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Standard Chem & Pharm Co
Its shares trade on Taiwan Stock Exchange under the ticker 1720.TW. It has been listed since 12 December 1995. In the fiscal year to 31 December 2025, it reported revenue of TWD 7.02bn and net income of TWD 927.7m. At that date it held total assets of TWD 11.80bn and shareholders' equity of TWD 6.12bn.
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of western medicine, medicine raw material, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 12 Dec 1995
- Website
- standard.com.tw ↗
Leadership
Pay as last reported
- Mr. Tzu-Ting FanChairman of the Board, General Manager, since 2005
- Mr. Chin-Wen ChangChief Financial Officer, Head of Finance & Accounting, Corporate Governance Officer
- Mr. Wen-Jang LinDeputy General Manager, Director, since 2000
- Mr. Wei-Ren ChenDeputy General Manager
- Mr. Chin-Tsai FanDirector, since 1967
- Mr. Yuan-Teh LeeDirector
- Ms. Tsuey-Wen YehDirector
- Mr. Lawrence C. LeeIndependent Director
- Ms. Lin-Yu LiIndependent Director
- Mr. Shao-Zong LiuIndependent Director
- Mr. Hwei-Jiung WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Standard Chem & Pharm Co Ltd has a strong reputation in the pharmaceutical industry, known for its quality products and customer satisfaction.
- The company has a well-established manufacturing infrastructure and a dedicated team of experienced professionals.
- Standard Chem & Pharm Co Ltd possesses a diverse product portfolio, catering to a wide range of therapeutic areas.
Weaknesses
- Despite its reputation, Standard Chem & Pharm Co Ltd has faced certain challenges in terms of supply chain management and maintaining consistent product availability.
- The company might lack innovation in comparison to some of its competitors, which could limit its ability to introduce new and groundbreaking pharmaceutical products.
- Standard Chem & Pharm Co Ltd may also have higher production costs due to the need for stringent quality control measures.
Opportunities
- Standard Chem & Pharm Co Ltd can take advantage of the growing demand for generic drugs in emerging markets, driving international expansion and revenue growth.
- The company can invest in research and development to enhance its product offerings and potentially enter new therapeutic areas.
- Standard Chem & Pharm Co Ltd can leverage advancements in technology and digitalization to streamline its operations and enhance customer engagement.
Threats
- Standard Chem & Pharm Co Ltd faces intense competition from both local and international pharmaceutical companies, which could impact market share and profitability.
- Changes in government regulations related to pharmaceutical manufacturing and pricing could pose challenges and impact the company's profitability.
- The company is susceptible to risks associated with intellectual property rights infringement and counterfeit drugs, requiring robust measures for detection and prevention.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.